Literature DB >> 22318400

Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.

J Menzin1, L A White, M Friedman, C Nichols, J Menzin1, J Hoesche, G E Bergman, C Jones.   

Abstract

This study assessed the frequency and factors associated with failure to correct international normalised ratio (INR) in patients administered fresh frozen plasma (FFP) for warfarin-related major bleeding. This retrospective database analysis used electronic health records from an integrated health system. Patients who received FFP between 01/01/2004 and 01/31/2010, and who met the following criteria were selected: major haemorrhage diagnosis the day before to the day after initial FFP administration; INR ≥2 on the day before or the day of FFP and another INR result available; warfarin prescription within 90 days. INR correction (defined as INR ≤1.3) was evaluated at the last available test up to one day following FFP. A total of 414 patients met selection criteria (mean age 75 years, 53% male, mean Charlson score 2.5). Patients presented with gastrointestinal bleeding (58%), intracranial haemorrhage (38%) and other bleed types (4%). The INR of 67% of patients remained uncorrected at the last available test up to one day following receipt of FFP. In logistic regression analysis, the INR of patients who were older, those with a Charlson score of 4 or greater, and those with non-ICH bleeds (odds ratio vs. intracranial bleeding 0.48; 95% confidence interval 0.31-0.76) were more likely to remain uncorrected within one day following FFP administration. In an alternative definition of correction, (INR ≤1.5), 39% of patients' INRs remained uncorrected. For a substantial proportion of patients, the INRs remain inadequately or uncorrected following FFP administration, with estimates varying depending on the INR threshold used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318400     DOI: 10.1160/TH11-09-0646

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

2.  Prophylactic Fresh Frozen Plasma Infusion is Ineffective in Reversing Warfarin Anticoagulation and Preventing Delayed Intracranial Hemorrhage After Falls.

Authors:  Subhash Reddy; Rohit Sharma; Jonathan Grotts; Lisa Ferrigno; Stephen Kaminski
Journal:  Neurohospitalist       Date:  2015-10

3.  Comorbidities against quality control of VKA therapy in non-valvular atrial fibrillation: a French national cross-sectional study.

Authors:  Agnes Rouaud; Olivier Hanon; Anne-Sophie Boureau; Guillaume Chapelet; Guillaume Gilles Chapelet; Laure de Decker
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

Review 4.  Coagulopathy reversal in intracerebral haemorrhage.

Authors:  Alexander Jacob Sweidan; Navneet Kaur Singh; Joseph Luke Conovaloff; Matthew Bower; Leonid I Groysman; Mohammad Shafie; Wengui Yu
Journal:  Stroke Vasc Neurol       Date:  2020-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.